Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage - A Randomised Clinically Controlled Trial.

Trial Profile

Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage - A Randomised Clinically Controlled Trial.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 02 Dec 2016

At a glance

  • Drugs Fibrinogen (Primary)
  • Indications Postpartum haemorrhage
  • Focus Therapeutic Use
  • Acronyms FIB-PPH
  • Most Recent Events

    • 13 Jul 2013 Status changed from recruiting to completed as reported by European Clinical Trials Database.
    • 18 Aug 2012 New source identified and integrated (European Clinical Trials Database: EudraCT2009-017736-41).
    • 18 Jun 2012 Additional lead trial investigator (Edwards HM) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top